Research and Markets: OTC Pharmaceuticals in Saudi Arabia To Reach A Value Of $2 Billion By The End Of 2015

Research and Markets (http://www.researchandmarkets.com/research/4t887n/otc_pharmaceutical) has announced the addition of the "OTC Pharmaceuticals in Saudi Arabia" report to their offering.

OTC Pharmaceuticals in Saudi Arabia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Saudi Arabia OTC pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

-The over-the-counter (OTC) pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.

-The Saudi Arabian OTC pharmaceuticals market generated total revenues of $1.5 billion in 2010, representing a compound annual growth rate (CAGR) of 9.4% for the period spanning 2006-2010.

-Traditional medicines sales proved the most lucrative for the Saudi Arabian OTC pharmaceuticals market in 2010, generating total revenues of $720.3 million, equivalent to 49.3% of the market's overall value.

-The performance of the market is forecast to decelerate, with an anticipated CAGR of 6% for the five-year period 2010-2015.

Companies Mentioned:

GlaxoSmithKline Plc.

Julphar

Johnson & Johnson

For more information visit http://www.researchandmarkets.com/research/4t887n/otc_pharmaceutical.